Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 08:12 am Purchase | 2021-12-31 | 13G | Immunic, Inc. IMUX | RTW Investments, LP | 1,715,470 6.500% | 1,715,470 (New Position) | Filing History |
| 2022-02-14 08:12 am Purchase | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | RTW Investments, LP | 5,810,140 9.990% | 422,627 (+7.84%) | Filing History |
| 2022-02-14 08:10 am Purchase | 2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR | RTW Investments, LP | 7,027,725 9.900% | 1,939,232 (+38.11%) | Filing History |
| 2022-02-14 08:09 am Sale | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | RTW Investments, LP | 190,656 5.100% | -77,922 (-29.01%) | Filing History |
| 2022-02-14 08:09 am Purchase | 2021-12-31 | 13G | Apyx Medical Corporation APYX | RTW Investments, LP | 3,398,279 9.900% | 7,000 (+0.21%) | Filing History |
| 2022-02-14 08:07 am Purchase | 2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW Investments, LP | 3,644,248 9.900% | 100,000 (+2.82%) | Filing History |
| 2022-02-14 08:07 am Sale | 2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | RTW Investments, LP | 2,599,822 5.400% | -1,050,247 (-28.77%) | Filing History |
| 2022-02-14 08:05 am Purchase | 2021-12-31 | 13G | Renovacor, Inc. RCOR | RTW Investments, LP | 2,997,540 17.000% | 2,997,540 (New Position) | Filing History |
| 2022-02-14 08:03 am Purchase | 2021-12-31 | 13G | BELLUS Health Inc. BLU | RTW Investments, LP | 5,968,017 5.800% | 778,155 (+14.99%) | Filing History |
| 2022-02-14 08:03 am Sale | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RTW Investments, LP | 4,315,102 14.400% | -99 (-0.00%) | Filing History |
| 2022-02-14 08:00 am Purchase | 2021-12-31 | 13G | PTC Therapeutics, Inc. PTCT | RTW Investments, LP | 5,293,966 7.500% | 325,757 (+6.56%) | Filing History |
| 2021-12-15 2:28 pm Purchase | 2021-12-06 | 13G | Adicet Bio, Inc. ACET | RTW Investments, LP | 188,984 7.910% | 188,984 (New Position) | Filing History |
| 2021-12-08 2:06 pm Purchase | 2021-11-29 | 13G | CytomX Therapeutics, Inc. CTMX | RTW Investments, LP | 5,868,326 8.990% | 5,868,326 (New Position) | Filing History |
| 2021-11-03 3:00 pm Purchase | 2021-10-25 | 13G | CUTERA INC CUTRQ | RTW Investments, LP | 1,375,663 7.670% | 1,375,663 (New Position) | Filing History |
| 2021-09-07 5:01 pm Purchase | 2021-09-02 | 13G | Chardan Healthcare Acquisition 2 Corp. CHAQ | RTW Investments, LP | 2,362,540 17.150% | 975,000 (+70.27%) | Filing History |
| 2021-08-31 5:08 pm Purchase | 2021-05-11 | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW Investments, LP | 16,272,635 25.300% | 87,516 (+0.54%) | Filing History |
| 2021-07-29 3:21 pm Purchase | 2021-07-22 | 13G | Chardan Healthcare Acquisition 2 Corp. CHAQ | RTW Investments, LP | 1,387,540 12.870% | 1,387,540 (New Position) | Filing History |
| 2021-07-02 09:18 am Purchase | 2021-06-24 | 13G | ESSA Pharma Inc. EPIX | RTW Investments, LP | 3,028,719 7.490% | 3,028,719 (New Position) | Filing History |
| 2021-05-18 4:12 pm Purchase | 2021-05-07 | 13G | LifeSci Acquisition II Corp. LSAQ | RTW Investments, LP | 975,000 9.740% | 325,000 (+50.00%) | Filing History |
| 2021-04-05 6:26 pm Purchase | 2021-02-01 | 13G | ProQR Therapeutics N.V. PRQR | RTW Investments, LP | 5,088,493 10.100% | 78,725 (+1.57%) | Filing History |